Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Qing Feng Xiang"'
Autor:
Qing-Feng Xiang, Mei-Xiao Zhan, Yong Li, Hui Liang, Cong Hu, Yao-Ming Huang, Jing Xiao, Xu He, Yong-Jie Xin, Min-Shan Chen, Li-Gong Lu
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 47, Iss 1, Pp 83-89 (2019)
Sorafenib is an oral multikinase inhibitor that has become an established therapeutic approach in advanced hepatocellular carcinoma (HCC). However, the benefit of sorafenib in clinical therapy is often affected by drug resistance. Therefore, it is im
Externí odkaz:
https://doaj.org/article/3ce1e71681d14eef8d264373ee7d1d9c
Application of Transparent Cap-assisted Choledochoscopy in Endoscopic Gallbladder-preserving Surgery
Autor:
Zhuo-Zhao Xie, Wei Jian, Jun-Bo Yang, Jia-Lin Liu, Rui-Kun Zhang, Yi-Ming Zhang, Qing-Feng Xiang, Yan-Zhou Song, Heng-Yu Tian
Publikováno v:
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. 30:317-321
Background The gold standard treatment for cholecystolithiasis is laparoscopic cholecystectomy. However, the complications of cholecystectomy have led to adoption of gallbladder-preserving surgery. The study was to investigate significance of transpa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef48c46ca421acf36e5b85d9d6a06639
https://doi.org/10.1097/sle.0000000000000786
https://doi.org/10.1097/sle.0000000000000786
Autor:
Ligong Lu, Xu He, Yong Jie Xin, Jing Xiao, Yao Ming Huang, Mei Xiao Zhan, Hui Liang, Cong Hu, Yong Li, Min Shan Chen, Qing Feng Xiang
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology. 47:83-89
Sorafenib is an oral multikinase inhibitor that has become an established therapeutic approach in advanced hepatocellular carcinoma (HCC). However, the benefit of sorafenib in clinical therapy is often affected by drug resistance. Therefore, it is im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80fe40979a89855a4b41bb836e5c95a6
https://doi.org/10.1080/21691401.2018.1543195
https://doi.org/10.1080/21691401.2018.1543195
Autor:
Yan Jun Mi, Qing Feng Xiang, Li Wu Fu, Fang Wang, Wei Qiang Chen, Yong Ju Liang, Li Sheng Zheng, Xiao Dong Su
Publikováno v:
Cellular oncology (Dordrecht). 34(1)
The overexpression of ATP-binding cassette (ABC) transporters is one of the main causes of multi-drug resistance (MDR) which represents a major obstacle to the success of cancer chemotherapy. In this study, we examined the effect of BIBF 1120, an inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e90ebaa0d1d67536356595bc4ab6311
https://pubmed.ncbi.nlm.nih.gov/21290212
https://pubmed.ncbi.nlm.nih.gov/21290212